Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Signet Ring Adenocarcinoma of the Rectum: early-phase trial registry
A small indexed set (2 trials) with no open enrollment listed right now.
Corpus placement: #7,188 of 28,707 conditions by registered trial count.
2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count
Signet Ring Adenocarcinoma of the Rectum: 2 US clinical trials tracked, none currently recruiting.
Signet Ring Adenocarcinoma of the Rectum is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is John Hays, running 1 of these trials.
Enrollment posture brief
Registry condition signet-ring-adenocarcinoma-of-the-rectum
OPEN 0 | RECR 0% | LATE 0 | EARLY 2 | RANK #7188 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)
Signet Ring Adenocarcinoma of the Rectum has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Signet Ring Adenocarcinoma of the Rectum on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Signet Ring Adenocarcinoma of the Rectum is recruiting below its size-band peers.
0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Indexed trials (enrollment closed)
2 total, page 1 of 1
CPI-613 and Fluorouracil in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed by Surgery
Wake Forest University Health Sciences
NCT02232152
Panitumumab and Chemotherapy in Patients With Advanced Colorectal Cancer After Prior Therapy With Bevacizumab
John Hays
NCT01814501
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Signet Ring Adenocarcinoma of the Rectum records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Signet Ring Adenocarcinoma of the Rectum trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Signet Ring Adenocarcinoma of the Rectum page
2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- No Signet Ring Adenocarcinoma of the Rectum trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- John Hays sponsors the most Signet Ring Adenocarcinoma of the Rectum trials on record, review their full trial history before evaluating a specific study. See John Hays's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Signet Ring Adenocarcinoma of the Rectum condition card totals 2 registered trials; most-linked intervention fluorouracil; top US site state Tennessee. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.